(1) A school district board of education of a public school, the state charter school institute for an institute charter school, or the governing board of a nonpublic school may adopt and implement a policy whereby:
A school under its jurisdiction may acquire and maintain a stock supply of opiateantagonists; and
An employee or agent of the school may, after receiving appropriate training, administer an opiate antagonist on school grounds to assist an individual who is at risk of experiencing an opiate-related drug overdose event. The training provided pursuant to this subsection (1)(b) must include risk factors for overdose, recognizing an overdose, calling emergency medical services, rescue breathing, and administering an opiate antagonist.
An employee or agent of a school acting in accordance with a policy adopted pursuant to this section is not subject to civil liability or criminal prosecution, as specified in sections 13-21-108.7 (3) and 18-1-712 (2), respectively.
As used in this section:
"Opiate antagonist" means naloxone hydrochloride or any similarly acting drug thatis not a controlled substance and that is approved by the federal food and drug administration for the treatment of a drug overdose.
"Opiate-related drug overdose event" means an acute condition, including a decreased level of consciousness or respiratory depression, that:
Results from the consumption or use of a controlled substance or another substancewith which a controlled substance was combined;
A layperson would reasonably believe to be caused by an opiate-related drug overdose event; and
Requires medical assistance.
Source: L. 2019: Entire section added, (SB 19-227), ch. 273, p. 2575, § 1, effective May 23.